Skip to main content

Table 5 Main adverse events at second line chemotherapy

From: Changing monoclonal antibody keeping unaltered the chemotherapy regimen in metastatic colorectal cancer patients: is efficacy maintained?

 

Grading

 

0

1

2

3

4

Neutropenia

39

7

6

2

0

Anaemia

40

12

1

1

0

Skin toxicity

16

17

17

4

0

Fatigue

37

8

8

1

0

Nausea/vomiting

46

8

0

0

0

Hypertension

54

0

0

0

0

Bleeding

54

0

0

0

0

Proteinuria

54

0

0

0

0

Diarrhea

28

14

11

1

0

Stomatitis

34

10

12

0

0